TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Peanut Butter
Play
INVESTING

Allergy-Medication Firm Aimmune Gets Added $200 Million Nestlé Investment

  • By Tony Owusu
  • Feb 5, 2020 10:10 AM EST
PRESS RELEASES

Xencor Enters Collaboration With Janssen With Aim To Discover Novel CD28 Bispecific Antibodies For The Treatment Of Prostate Cancer

  • By Business Wire
  • Dec 7, 2020 8:01 AM EST
PRESS RELEASES

Xencor Presents Updated Data From The Phase 1 Study Of Vibecotamab In Acute Myeloid Leukemia At The 2020 ASH Annual Meeting

  • By Business Wire
  • Dec 6, 2020 5:00 PM EST
PRESS RELEASES

Xencor To Present At Upcoming Investor Conferences

  • By Business Wire
  • Nov 12, 2020 4:01 PM EST
PRESS RELEASES

Xencor, MorphoSys And Incyte Enter Into Global Development Collaboration For Tafasitamab In Combination With Plamotamab

  • By Business Wire
  • Nov 11, 2020 4:02 PM EST
PRESS RELEASES

Xencor Presents Data From Multiple Preclinical XmAb® Bispecific Antibody And Cytokine Programs At The SITC Annual Meeting

  • By Business Wire
  • Nov 9, 2020 8:00 AM EST
PRESS RELEASES

Xencor To Present Data From Phase 1 Study Of Vibecotamab In Acute Myeloid Leukemia At The 2020 ASH Annual Meeting

  • By Business Wire
  • Nov 4, 2020 10:15 AM EST
PRESS RELEASES

Xencor To Host Third Quarter 2020 Financial Results Webcast And Conference Call On November 5, 2020

  • By Business Wire
  • Oct 29, 2020 4:01 PM EDT
PRESS RELEASES

Xencor To Present Data From The Phase 1 Study Of XmAb®20717 And Three Research Programs At The SITC Annual Meeting

  • By Business Wire
  • Oct 14, 2020 5:00 PM EDT
PRESS RELEASES

Xencor Presents Initial Data From The Phase 1 Study Of Tidutamab In Neuroendocrine Tumors At NANETS' Multidisciplinary NET Medical Virtual Symposium

  • By Business Wire
  • Oct 2, 2020 9:00 AM EDT
PRESS RELEASES

Xencor To Present At The 2020 Cantor Fitzgerald Virtual Global Healthcare Conference

  • By Business Wire
  • Sep 9, 2020 4:01 PM EDT
PRESS RELEASES

Xencor And MD Anderson Enter Strategic Collaboration To Advance Investigational XmAb® Drug Candidates

  • By Business Wire
  • Sep 3, 2020 8:01 AM EDT
PRESS RELEASES

Xencor To Present At Upcoming Investor Conferences

  • By Business Wire
  • Aug 5, 2020 4:01 PM EDT
PRESS RELEASES

Xencor Earns Milestone Payment From MorphoSys For FDA Approval Of Monjuvi® (tafasitamab-cxix) In The United States

  • By Business Wire
  • Jul 31, 2020 10:49 PM EDT
PRESS RELEASES

Xencor To Host Second Quarter 2020 Financial Results Webcast And Conference Call On August 4, 2020

  • By Business Wire
  • Jul 28, 2020 5:01 PM EDT
PRESS RELEASES

Atreca And Xencor Enter Strategic Collaboration To Discover, Develop And Commercialize Novel T Cell Engaging Bispecific Antibodies

  • By GlobeNewswire
  • Jul 8, 2020 8:01 AM EDT
PRESS RELEASES

Xencor And Atreca Enter Strategic Collaboration To Discover, Develop And Commercialize Novel T Cell Engaging Bispecific Antibodies

  • By Business Wire
  • Jul 8, 2020 8:01 AM EDT
PRESS RELEASES

Xencor Presents Data From Four Preclinical XmAb® 2 1 Bispecific Antibody And Cytokine Programs At AACR Virtual Annual Meeting II

  • By Business Wire
  • Jun 22, 2020 9:06 AM EDT
PRESS RELEASES

Xencor To Present At Upcoming Investor Conferences

  • By Business Wire
  • May 26, 2020 4:01 PM EDT
PRESS RELEASES

Xencor To Present Data From Four Preclinical XmAb® 2 1 Bispecific Antibody And Cytokine Programs At AACR Virtual Annual Meeting II

  • By Business Wire
  • May 15, 2020 12:01 AM EDT
PRESS RELEASES

Xencor To Present At The 2020 RBC Capital Markets Global Healthcare Virtual Conference

  • By Business Wire
  • May 13, 2020 9:01 AM EDT
PRESS RELEASES

Xencor To Host First Quarter 2020 Financial Results Webcast And Conference Call On May 7, 2020

  • By Business Wire
  • Apr 30, 2020 4:01 PM EDT
PRESS RELEASES

Xencor And Vir Biotechnology Enter License Agreement For Use Of Xtend™ XmAb® Antibody Technology In Investigational Antibodies To Treat COVID-19

  • By Business Wire
  • Mar 25, 2020 4:01 PM EDT
PRESS RELEASES

Xencor To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call On February 24, 2020

  • By Business Wire
  • Feb 18, 2020 8:01 AM EST
PRESS RELEASES

Xencor To Present At Upcoming Investor Conferences

  • By Business Wire
  • Feb 6, 2020 4:01 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.